Jane Street’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.26M | Sell |
246,199
-9,893
| -4% | -$171K | ﹤0.01% | 1455 |
|
2025
Q1 | $5.6M | Buy |
256,092
+160,107
| +167% | +$3.5M | ﹤0.01% | 1274 |
|
2024
Q4 | $3.06M | Buy |
95,985
+76,705
| +398% | +$2.45M | ﹤0.01% | 1621 |
|
2024
Q3 | $556K | Sell |
19,280
-181,609
| -90% | -$5.24M | ﹤0.01% | 4169 |
|
2024
Q2 | $7.71M | Buy |
200,889
+71,880
| +56% | +$2.76M | ﹤0.01% | 1260 |
|
2024
Q1 | $7.58M | Sell |
129,009
-305,692
| -70% | -$18M | ﹤0.01% | 982 |
|
2023
Q4 | $26M | Buy |
434,701
+161,475
| +59% | +$9.67M | 0.01% | 435 |
|
2023
Q3 | $10.4M | Sell |
273,226
-207,856
| -43% | -$7.91M | ﹤0.01% | 809 |
|
2023
Q2 | $43.8M | Buy |
481,082
+417,698
| +659% | +$38.1M | 0.01% | 271 |
|
2023
Q1 | $4.18M | Buy |
63,384
+49,363
| +352% | +$3.26M | ﹤0.01% | 1343 |
|
2022
Q4 | $725K | Sell |
14,021
-2,977
| -18% | -$154K | ﹤0.01% | 3001 |
|
2022
Q3 | $1.16M | Sell |
16,998
-77,584
| -82% | -$5.3M | ﹤0.01% | 2634 |
|
2022
Q2 | $4.28M | Buy |
94,582
+19,472
| +26% | +$881K | ﹤0.01% | 1233 |
|
2022
Q1 | $3.82M | Sell |
75,110
-25,601
| -25% | -$1.3M | ﹤0.01% | 1442 |
|
2021
Q4 | $4.76M | Buy |
100,711
+84,768
| +532% | +$4.01M | ﹤0.01% | 1118 |
|
2021
Q3 | $525K | Sell |
15,943
-18,619
| -54% | -$613K | ﹤0.01% | 3376 |
|
2021
Q2 | $2.18M | Buy |
34,562
+11,464
| +50% | +$724K | ﹤0.01% | 1683 |
|
2021
Q1 | $991K | Sell |
23,098
-33,854
| -59% | -$1.45M | ﹤0.01% | 2518 |
|
2020
Q4 | $3.26M | Buy |
56,952
+14,382
| +34% | +$823K | ﹤0.01% | 1017 |
|
2020
Q3 | $1.28M | Buy |
42,570
+19,591
| +85% | +$591K | ﹤0.01% | 1558 |
|
2020
Q2 | $750K | Buy |
+22,979
| New | +$750K | ﹤0.01% | 2194 |
|
2020
Q1 | – | Sell |
-8,135
| Closed | -$249K | – | 3389 |
|
2019
Q4 | $249K | Sell |
8,135
-87,589
| -92% | -$2.68M | ﹤0.01% | 2844 |
|
2019
Q3 | $2.31M | Buy |
95,724
+82,285
| +612% | +$1.98M | ﹤0.01% | 837 |
|
2019
Q2 | $341K | Buy |
+13,439
| New | +$341K | ﹤0.01% | 2623 |
|